More people now use GLP-1s to lose weight than for other health issues
Growing usage of GLP-1 drugs for weight loss is reshaping how consumers shop for food and clothes, according to consulting firm EY-Parthenon.
Watch CBS News
Growing usage of GLP-1 drugs for weight loss is reshaping how consumers shop for food and clothes, according to consulting firm EY-Parthenon.
President Trump announced a deal with Eli Lilly and Novo Nordisk on Thursday to lower the cost of their weight loss drugs for some Americans. Dr. Holly Lofton, NYU Langone Medical's weight management program director, joins "The Daily Report" to discuss.
A new clinical trial is showing promising results for a new pill to help treat diabetes and support weight loss. CBS News chief medical correspondent Dr. Jon LaPook explains.
The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on whether the supply change could lead to consumers paying more.
The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these counterfeit medicines can be harmful to people's health. Tom Hanson has more.
Attention red meat lovers: Eating more than one serving per week is associated with a higher risk of Type 2 diabetes, according to a new study.
The White House on Tuesday released a list of 10 medications that will be subject to price negotiations under Medicare. Ed O'Keefe reports on how this could affect prices and what other drugs could be added going forward.
"Trends indicate that demand for Wegovy in the U.S. will exceed our current supply capacity," the company said in an announcement.
Health experts are pushing diabetes prevention during Hispanic Heritage Month. As CBS News' Debra Alfarone reports, health care providers are helping one Hispanic community in Maryland lower their risk to the disease.
Millions of Americans have prediabetes, yet the majority don't know it
New research shows these lifestyle habits can significantly reduce the risk of both heart disease and diabetes
Many don't even know they have the blood sugar disease, a new report shows
Rare but serious genital infections, as well as one death, have been reported in some patients taking a certain class of type 2 diabetes medications
New research suggests that a single blood test could accurately confirm type 2 diabetes
A prominent group of primary care physicians loosened type 2 diabetes targets, but doctors who specialize in diabetes treatment disagree
The new therapy, a once-a-week shot, appears to be more effective than a popular daily diabetes pill, a study shows
Newest study shows an almost 5 percent jump in the disease over a decade for those between the ages of 10 and 19
The device, approved for adults with Type 1 or Type 2 diabetes, should be available in pharmacies within months
From the American Diabetes Association’s Alert Day to Bob Dylan’s latest album, “Sunday Morning” takes a look at some notable events of the week ahead
Aggressive treatment can make a big difference in reducing serious complications
Rates of type 2 diabetes are rising, and an even larger group has condition that puts them at high risk of developing it
Low verbal fluency could be early signal of dementia, researchers say
Why isn't there cheap, generic insulin for diabetes? Report looks at drug company practices that dominate the market